These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 8874660
1. Effects of interleukin (IL)-3 and IL-5 on human eosinophil degranulation induced by complement components C3a and C5a. Takafuji S, Tadokoro K, Ito K. Allergy; 1996 Aug; 51(8):563-8. PubMed ID: 8874660 [Abstract] [Full Text] [Related]
2. Degranulation from human eosinophils stimulated with C3a and C5a. Takafuji S, Tadokoro K, Ito K, Dahinden CA. Int Arch Allergy Immunol; 1994 Aug; 104 Suppl 1(1):27-9. PubMed ID: 8156000 [Abstract] [Full Text] [Related]
4. Eosinophil degranulation in the presence of bronchial epithelial cells. Effect of cytokines and role of adhesion. Takafuji S, Ohtoshi T, Takizawa H, Tadokoro K, Ito K. J Immunol; 1996 May 15; 156(10):3980-5. PubMed ID: 8621939 [Abstract] [Full Text] [Related]
5. Eosinophil degranulation in the presence of lung fibroblasts. Takafuji S, Shoji S, Ito K, Yamamoto K, Nakagawa T. Int Arch Allergy Immunol; 1998 Sep 15; 117 Suppl 1():52-4. PubMed ID: 9758898 [Abstract] [Full Text] [Related]
7. Phorbol ester-induced degranulation in adherent human eosinophil granulocytes is dependent on CD11/CD18 leukocyte integrins. Egesten A, Gullberg U, Olsson I, Richter J. J Leukoc Biol; 1993 Mar 15; 53(3):287-93. PubMed ID: 8095965 [Abstract] [Full Text] [Related]
8. Eosinophil leukocyte degranulation in response to serum-opsonized beads: C5a and platelet-activating factor enhance ECP release, with roles for protein kinases A and C. Egesten A, Malm J. Allergy; 1998 Nov 15; 53(11):1066-73. PubMed ID: 9860239 [Abstract] [Full Text] [Related]
9. Mechanisms of human eosinophil activation by complement protein C5a and platelet-activating factor: similar functional responses are accompanied by different morphologic alterations. Zeck-Kapp G, Kroegel C, Riede UN, Kapp A. Allergy; 1995 Jan 15; 50(1):34-47. PubMed ID: 7741187 [Abstract] [Full Text] [Related]
11. Eosinophils maintain their capacity to signal and release eosinophil cationic protein upon repetitive stimulation with the same agonist. Simon HU, Weber M, Becker E, Zilberman Y, Blaser K, Levi-Schaffer F. J Immunol; 2000 Oct 01; 165(7):4069-75. PubMed ID: 11034418 [Abstract] [Full Text] [Related]
12. Regulation of the release of eosinophil cationic protein by eosinophil adhesion. Xu X, Håkansson L. Clin Exp Allergy; 2000 Jun 01; 30(6):794-806. PubMed ID: 10848898 [Abstract] [Full Text] [Related]
15. Release of granule proteins from human eosinophils stimulated with mast-cell mediators. Takafuji S, Tadokoro K, Ito K, Nakagawa T. Allergy; 1998 Oct 01; 53(10):951-6. PubMed ID: 9821474 [Abstract] [Full Text] [Related]
19. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. Rot A, Krieger M, Brunner T, Bischoff SC, Schall TJ, Dahinden CA. J Exp Med; 1992 Dec 01; 176(6):1489-95. PubMed ID: 1281207 [Abstract] [Full Text] [Related]
20. Effects of rapamycin, cyclosporin A, and dexamethasone on interleukin 5-induced eosinophil degranulation and prolonged survival. Meng Q, Ying S, Corrigan CJ, Wakelin M, Assoufi B, Moqbel R, Kay AB. Allergy; 1997 Nov 01; 52(11):1095-101. PubMed ID: 9404561 [Abstract] [Full Text] [Related] Page: [Next] [New Search]